{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:10:02Z","timestamp":1789996202801,"version":"4.0.1"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T00:00:00Z","timestamp":1509408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0186211","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T13:31:39Z","timestamp":1509456699000},"page":"e0186211","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":52,"title":["Immunogenicity of glycans on biotherapeutic drugs produced in plant expression systems\u2014The taliglucerase alfa story"],"prefix":"10.1371","volume":"12","author":[{"given":"Bonita","family":"Rup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Alon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bat-Chen","family":"Amit-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einat","family":"Brill Almon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Chertkoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6134-059X","authenticated-orcid":true,"given":"Yoram","family":"Tekoah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline M.","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,10,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.biotechadv.2011.08.007","article-title":"GMP issues for recombinant plant-derived pharmaceutical proteins","volume":"30","author":"R Fischer","year":"2011","journal-title":"Biotechnology Advances"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s000180300037","article-title":"Molecular farming of recombinant antibodies in plants","volume":"60","author":"S Schillberg","year":"2003","journal-title":"Cell. Mol. Life Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e4792","DOI":"10.1371\/journal.pone.0004792","article-title":"A Plant-Derived Recombinant Human Glucocerebrosidase Enzyme\u2014A Preclinical and Phase I Investigation","volume":"4","author":"D Aviezer","year":"2009","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/pbi.12428","article-title":"Large Scale Production of Pharmaceutical Proteins in Plant Cell Culture\u2014The Protalix Experience","volume":"13","author":"Y Tekoah","year":"2015","journal-title":"Plant Biotechnol. J"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1385\/MB:28:3:241","article-title":"Appropriate glycosylation of recombinant proteins for human use","volume":"28","author":"SA Brooks","year":"2004","journal-title":"Molecular Biotechnology"},{"key":"ref6","first-page":"181","article-title":"Anticarbohydrate antibodies: from molecular basis to clinical application","author":"W Hemmer","year":"2012"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000096114","article-title":"The Role of Protein Glycosylation in Allergy","volume":"142","author":"F Altmann","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1067\/mai.2003.173","article-title":"Biological activity of IgE specific for cross-reactive carbohydrate determinants","volume":"111","author":"K Foetisch","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/j.1365-2222.2006.02587.x","article-title":"Natural rubber latex and hymenoptera venoms share Immunoglobin E-epitopes accounting for cross-reactive carbohydrate determinants","volume":"36","author":"V Mahler","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000067591","article-title":"IgE to Cross-Reactive Carbohydrate Determinants: Analysis of the Distribution and Appraisal of the in vivo and in vitro Reactivity","volume":"129","author":"A Mari","year":"2002","journal-title":"Int Arch of Allergy and Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1398-9995.2008.01703.x","article-title":"Evaluation by double-blind placebo-controlled oral challenge of the clinical relevance of IgE antibodies against plant glycans","volume":"63","author":"A Mari","year":"2008","journal-title":"Allergy"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000066770","article-title":"Carbohydrate Epitopes and Their Relevance for the Diagnosis and Treatment of Allergic Diseases","volume":"129","author":"R van Ree","year":"2002","journal-title":"Int Arch of Allergy and Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/glycob\/cwg024","article-title":"Immunoreactivity in mammals of two typical plant glyco-epitopes, core \u03b1(1,3)-fucose and core xylose","volume":"13","author":"M Bardor","year":"2003","journal-title":"Glycobiology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1360-1385(99)01461-2","article-title":"Analysis of the N-glycosylation of recombinant glycoproteins produced in transgenic plants","volume":"4","author":"M Bardor","year":"1999","journal-title":"Trends Plant Sci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1467-7652.2007.00273.x","article-title":"Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern","volume":"5","author":"M Sch\u00e4hs","year":"2007","journal-title":"Plant Biotechnol J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1023\/A:1008976219939","article-title":"A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice","volume":"9","author":"D Chargelegue","year":"2000","journal-title":"Transgenic Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/abio.1993.1088","article-title":"Affinity purification of antibodies specific for Asn-linked glycans containing \u03b11\u21923 fucose or \u03b21\u21922 xylose","volume":"209","author":"L Faye","year":"1993","journal-title":"Anal. Biochem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/glycob\/cwj071","article-title":"Immunoglobulin G specifically binding plant N-glycans with high affinity could be generated in rabbits but not in mice","volume":"16","author":"C Jin","year":"2006","journal-title":"Glycobiology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1016\/S0021-9258(20)64302-2","article-title":"The structure of a neural specific carbohydrate epitope of horseradish peroxidase recognized by anti-horseradish peroxidase antiserum","volume":"266","author":"A Kurosaka","year":"1991","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0031-9422(00)89507-2","article-title":"Immunogenicity of the N-glycans of peanut peroxidase","volume":"37","author":"W Lianglu","year":"1994","journal-title":"Phytochemistry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/BF00393072","article-title":"Identification of a monoclonal antibody to abscission tissue that recognises xylose\/fucose-containing N-linked oligosaccharides from higher plants","volume":"175","author":"MT McManus","year":"1988","journal-title":"Planta"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1467-7652.2006.00200.x","article-title":"A KDEL-tagged monoclonal antibody is efficiently retained in the endoplasmic reticulum in leaves, but is both partially secreted and sorted to protein storage vacuoles in seeds","volume":"4","author":"S Petruccelli","year":"2006","journal-title":"Plant Biotechnol J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0008-6215(00)90595-0","article-title":"The (1\u21923)-linked \u03b1-L-fucosyl group of the N-glycans of the Wistaria floribunda lectins is recognized by a rabbit anti-serum","volume":"213","author":"D Ramirez-Soto","year":"1991","journal-title":"Carbohydr. Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/glycob\/8.7.651","article-title":"Core \u03b11,3-fucose is a key part of the epitope recognized by antibodies reacting against plant N-linked oligosaccharides and is present in a wide variety of plant extracts","volume":"8","author":"IBH Wilson","year":"1998","journal-title":"Glycobiology"},{"key":"ref25","first-page":"325","article-title":"Recombinant Proteins From Plants: Methods and Protocols","author":"PD Chamberlain","year":"2009"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1208\/s12248-009-9165-5","article-title":"Prevalence and Isotypic Complexity of the Anti-Chinese Hamster Ovary Host Cell Protein Antibodies in Normal Human Serum","volume":"12","author":"L Xue","year":"2010","journal-title":"AAPS J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2005.01.022","article-title":"IgG antibodies against bovine serum albumin in humans\u2014their prevalence and response to exposure to bovine serum albumin","volume":"300","author":"T Mogues","year":"2005","journal-title":"J Immunol Methods"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.vascn.2011.07.003","article-title":"A double antigen bridging immunogenicity ELISA for the detection of antibodies to polyethylene glycol polymers","volume":"64","author":"Y Liu","year":"2011","journal-title":"J Pharmacol Toxicol Methods"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e15559","DOI":"10.1371\/journal.pone.0015559","article-title":"Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza","volume":"5","author":"N Landry","year":"2010","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1016\/j.vaccine.2014.08.079","article-title":"Human antibody response to N-glycans present on plant-made influenza virus-like particle (VLP) vaccines","volume":"32","author":"BJ Ward","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nbt0612-472","article-title":"First plant-made biologic approved","volume":"30","author":"JL Fox","year":"2012","journal-title":"Nat Biotech"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e00071","DOI":"10.1042\/BSR20130081","article-title":"Glycosylation and functionality of recombinant \u03b2-glucocerebrosidase from various production systems","volume":"33","author":"Y Tekoah","year":"2013","journal-title":"Biosci. Rep"},{"issue":"9","key":"ref33","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/1060028013500469","article-title":"Gaucher disease and its treatment options","volume":"47","author":"LL Bennett","year":"2013","journal-title":"Ann Pharmacother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0140-6736(95)91038-7","article-title":"Replacement therapy with imiglucerase for type 1 Gaucher\u2019s disease","volume":"345","author":"A Zimran","year":"1995","journal-title":"Lancet"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1182\/blood-2011-04-308890","article-title":"How I treat Gaucher disease","volume":"118","author":"A Zimran","year":"2011","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1467-7652.2007.00263.x","article-title":"Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher\u2019s disease using a plant cell system","volume":"5","author":"Y Shaaltiel","year":"2007","journal-title":"Plant Biotech J"},{"issue":"22","key":"ref37","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1182\/blood-2011-07-366955","article-title":"Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease","volume":"118","author":"A Zimran","year":"2011","journal-title":"Blood"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bcmd.2014.05.004","article-title":"A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase","volume":"53","author":"GM Pastores","year":"2014","journal-title":"Blood Cells, Molecules, and Diseases"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bcmd.2014.10.002","article-title":"Safety and efficacy of two dose levels of taliglucerase alfa in pediatric patients with Gaucher disease","volume":"54","author":"A Zimran","year":"2015","journal-title":"Blood Cells, Molecules, and Diseases"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.abb.2004.02.034","article-title":"Controlled glycosylation of therapeutic antibodies in plants","volume":"426","author":"Y Tekoah","year":"2004","journal-title":"Arch. Biochem. Biophys"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/bioinformatics\/btn090","article-title":"GlycoBase and autoGU: tools for HPLC-based glycan analysis","volume":"24","author":"MP Campbell","year":"2008","journal-title":"Bioinformatics"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jpba.2008.09.020","article-title":"Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products","volume":"48","author":"G Shankar","year":"2008","journal-title":"J Pharm Biomed Anal"},{"key":"ref43","unstructured":"FDA, Guidance for Industry: Assay Development for Immunogenicity Testing of Therapeutic Proteins. FDA, MD, USA, 2009."},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2004.06.002","article-title":"Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products","volume":"289","author":"AR Mire-Sluis","year":"2004","journal-title":"J. Immunol. Methods"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/cei.12652","article-title":"Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium","volume":"181","author":"B Rup","year":"2015","journal-title":"Clinical & Experimental Immunology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.genom.4.070802.110415","article-title":"Enzyme therapy for lysosomal storage disease: principles, practice and prospects","volume":"4","author":"GA Grabowski","year":"2003","journal-title":"Annu. Rev. Genomics Hum. Genet"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","article-title":"Gaucher disease: pathological mechanisms and modern management","volume":"129","author":"M Jmoudiak","year":"2005","journal-title":"Br J Haematol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/rcm.1546","article-title":"Glycopeptide analysis by matrix-assisted laser desorption\/ionization tandem time-of-flight mass spectrometry reveals novel features of horseradish peroxidase glycosylation","volume":"18","author":"M Wuhrer","year":"2004","journal-title":"Rapid Commun. Mass Spectrom"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1208\/s12248-013-9492-4","article-title":"Pre-Existing Biotherapeutic-Reactive Antibodies: Survey Results Within the American Association of Pharmaceutical Scientists","volume":"15","author":"L Xue","year":"2013","journal-title":"AAPS J"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1208\/s12248-013-9497-z","article-title":"Evaluation of Pre-existing Antibody Presence as a Risk Factor for Posttreatment Anti-drug Antibody Induction: Analysis of Human Clinical Study Data for Multiple Biotherapeutics","volume":"15","author":"L Xue","year":"2013","journal-title":"AAPS J"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"10018","DOI":"10.1073\/pnas.1200941109","article-title":"Gaucher disease gene GBA functions in immune regulation","volume":"109","author":"J Liu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nbt.3556","article-title":"Plant specific N-glycans do not have proven adverse effects in humans","volume":"34","author":"Y Shaaltiel","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymgme.2015.11.001","article-title":"Immune response to enzyme replacement therapies in lysosomal storage diseases and the role of immune tolerance induction","volume":"117","author":"PS Kishnani","year":"2016","journal-title":"Molecular Genetics and Metabolism"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0186211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T01:36:06Z","timestamp":1719538566000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0186211"}},"subtitle":[],"editor":[{"given":"Raphael","family":"Schiffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,31]]},"references-count":53,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0186211","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,31]]}}}